Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vivo

Currently viewing:

Administrative data

Endpoint:
in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
Remarks:
Type of genotoxicity: chromosome aberration
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: published well documented GLP guideline study

Data source

Reference
Reference Type:
publication
Title:
Safety assessment of N-acetyl-L-threonine.
Author:
van de Mortel EL, Shen ZA, Barnett JF Jr, Krsmanovic L, Myhre A, Delaney BF.
Year:
2010
Bibliographic source:
Food Chem Toxicol. 2010 Jul;48(7):1919-25

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
GLP compliance:
yes
Type of assay:
micronucleus assay

Test material

Constituent 1
Chemical structure
Reference substance name:
L-threonine
EC Number:
200-774-1
EC Name:
L-threonine
Cas Number:
72-19-5
Molecular formula:
C4H9NO3
IUPAC Name:
L-threonine
Details on test material:
- Name of test material (as cited in study report): Thr (CAS No. 72-19-5)
- Analytical purity: 100 % (LC/MSD method)
- Other: supplier: Sigma-Aldrich (St.Louis, MO)

Test animals

Species:
mouse
Strain:
ICR
Sex:
male/female

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
- Vehicle(s)/solvent(s) used: sterile water
- Amount of vehicle (if gavage or dermal): 20 ml/kg bw
Duration of treatment / exposure:
24 h and 48 h
Frequency of treatment:
a single oral gavage
Doses / concentrationsopen allclose all
Remarks:
Doses / Concentrations:
500 mg/kg bw
Basis:

Remarks:
Doses / Concentrations:
1000 mg/kg bw
Basis:

Remarks:
Doses / Concentrations:
2000 mg/kg bw
Basis:

No. of animals per sex per dose:
10 male and 10 female / dose
Control animals:
yes, concurrent vehicle
Positive control(s):
cyclophosphamide

- Route of administration: oral gavage
- Doses / concentrations: 50mg/kg

Examinations

Details of tissue and slide preparation:
DETAILS OF SLIDE PREPARATION: femoral bone marrow was collected, bone marrow smears were prepared and stained with May-Grunwald-Giemsa stain

METHOD OF ANALYSIS: The incidence of MPCEs per 10000 PCEs per group (2000 PCEs per each animal) served as parameter of genotoxicity.

OTHER:
Evaluation criteria:
The incidence of MPCEs per 10000 PCEs per group (2000 PCEs per each animal) served as parameter of genotoxicity.
Statistics:
Kastenbaum-Bowman tables (ninominal distribution, p

Results and discussion

Test results
Sex:
male/female
Genotoxicity:
negative

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information): negative
A single oral gavage of test substance at doses up to 2000 mg/kg bw did not induce a significant increase in the incidence of MPCEs in the bone marrow of male or female ICR mice.